文献速递关节外科

使用患者报告结局指标指导髋膝关节置换术转诊

The use of patient-reported outcome measures to guide referral for hip and knee arthroplasty.
PubMed 文献 · Bone Joint J · 2020-01-01

该研究采用英国NHS视角的马尔可夫模型进行成本效果分析,评估全髋关节置换术(THA)和全膝关节置换术(TKA)的成本效果如何随年龄、性别和术前牛津髋/膝关节评分(OHS/OKS)变化,并识别THA/TKA具有成本效果的患者群体。结果显示,在所有低于先前计算的绝对转诊阈值(OHS 40,OKS 41)的术前评分下,THA和TKA每获得一个质量调整生命年(QALY)的成本均低于7000英镑;THA在OHS≤45时成本低于20000英镑/QALY,TKA在OKS≤43时具有成本效果。结论认为,若社会愿意为每QALY支付20000英镑,THA和TKA对几乎所有目前接受手术的患者具有成本效果,包括所有达到或超过所计算绝对转诊阈值的患者。

要点

  • THA和TKA在所有低于绝对转诊阈值(OHS 40,OKS 41)的术前评分下,每QALY成本均低于7000英镑。
  • THA在OHS≤45时每QALY成本低于20000英镑,TKA在OKS≤43时具有成本效果。
  • 若社会愿意支付20000英镑/QALY,THA和TKA对几乎所有目前手术患者具有成本效果。

核心结论

  • 若社会愿意为每QALY支付20000英镑,THA和TKA对几乎所有目前接受手术的患者具有成本效果,包括所有达到或超过所计算绝对转诊阈值的患者。

研究设计与样本

  • 采用英国NHS视角的马尔可夫模型进行成本效果分析,基于已发表的患者水平数据分析,评估成人髋或膝关节骨关节炎患者接受THA或TKA与不进行关节置换手术相比在十年时间范围内的成本效果。

主要发现

  • 在所有低于先前计算的绝对转诊阈值(OHS 40,OKS 41)的术前评分下,THA和TKA每获得一个QALY的成本均低于7000英镑。
  • THA在OHS≤45时每QALY成本低于20000英镑,TKA在OKS≤43时具有成本效果,因为生活质量的微小改善超过了手术及后续翻修的成本。
  • 概率敏感性分析和单因素敏感性分析显示结论的不确定性很小。

关键数值与推荐

  • THA和TKA在所有低于绝对转诊阈值(OHS 40,OKS 41)的术前评分下,每QALY成本均低于7000英镑。
  • THA在OHS≤45时每QALY成本低于20000英镑。
  • TKA在OKS≤43时具有成本效果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To assess how the cost-effectiveness of total hip arthroplasty (THA) and total knee arthroplasty (TKA) varies with age, sex, and preoperative Oxford Hip or Knee Score (OHS/OKS); and to identify the patient groups for whom THA/TKA is cost-effective. METHODS: We conducted a cost-effectiveness analysis using a Markov model from a United Kingdom NHS perspective, informed by published analyses of patient-level data. We assessed the cost-effectiveness of THA and TKA in adults with hip or knee osteoarthritis compared with having no arthroplasty surgery during the ten-year time horizon. RESULTS: THA and TKA cost < £7,000 per quality-adjusted life-year (QALY) gained at all preoperative scores below the absolute referral thresholds calculated previously (40 for OHS and 41 for OKS). Furthermore, THA cost < £20,000/QALY for patients with OHS of ≤ 45, while TKA was cost-effective for patients with OKS of ≤ 43, since the small improvements in quality of life outweighed the cost of surgery and any subsequent revisions. Probabilistic and one-way sensitivity analyses demonstrated that there is little uncertainty around the conclusions. CONCLUSION: If society is willing to pay £20,000 per QALY gained, THA and TKA are cost-effective for nearly all patients who currently undergo surgery, including all patients at and above our calculated absolute referral thresholds. Cite this article: Bone Joint J 2020;102-B(7):950-958.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Dakin H, Eibich P, Beard D, et al. The use of patient-reported outcome measures to guide referral for hip and knee arthroplasty. Bone Joint J. 2020. PMID: 32600136. doi:10.1302/0301-620X.102B7.BJJ-2019-0105.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。